A phase I study of gemcitabine, 5-fluorouracil and leucovorin in patients with advanced, recurrent, and/or metastatic solid tumors

被引：0
|
作者：
Jordan D. Berlin
Dona B. Alberti
Rhoda Z. Arzoomanian
Chris A. Feierabend
Kris J. Simon
Kim A. Binger
Rebecca M. Marnocha
George Wilding
机构：
[1] University of Wisconsin,Division of Oncology
来源：
Investigational New Drugs | 1998年 / 16卷
关键词：
gemcitabine; 5-fluorouracil; leucovorin; phase I study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Introduction: This was a dose escalation phase I trial designed to establish the MTD (maximum tolerated dose) and toxicity profile of the combination of gemcitabine, leucovorin and 5-fluorouracil (5-FU).
引用
收藏
页码：325 / 330
页数：5
相关论文
共 50 条
  • [31] A phase I study of sequential irinotecan and 5-fluorouracil/leucovorin
    Goldberg, RM
    Kaufmann, SH
    Atherton, P
    Sloan, JA
    Adjei, AA
    Pitot, HC
    Alberts, SR
    Rubin, J
    Miller, LL
    Erlichman, C
    ANNALS OF ONCOLOGY, 2002, 13 (10) : 1674 - 1680
  • [32] A phase I study of docetaxel, cisplatin, 5-fluorouracil and leucovorin
    Mulcahy, MF
    Loehrer, PJ
    Meropol, NJ
    Rademaker, AW
    Benson, AB
    ONCOLOGY, 2005, 68 (4-6) : 479 - 484
  • [33] Phase I study of 5-fluorouracil and leucovorin by continuous infusion chronotherapy and pelvic radiotherapy in patients with locally advanced or recurrent rectal cancer
    Parulekar, W
    De Marsh, RW
    Wong, R
    Mendenhall, W
    Davey, P
    Zlotecki, R
    Berry, S
    Rout, WR
    Bjarnason, GA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (05): : 1487 - 1495
  • [34] PHASE-I AND PHARMACOLOGICAL STUDIES OF INTRAPERITONEAL LEUCOVORIN AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED CANCER
    ARBUCK, SG
    TRAVE, F
    DOUGLASS, HO
    NAVA, H
    ZAKRZEWSKI, S
    RUSTUM, YM
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (10) : 1510 - 1517
  • [35] Phase I trial of BAY 43-9006 in combination with 5-fluorouracil (5-FU) and leucovorin (LCV) in patients with advanced refractory solid tumors
    Figer, A.
    Moscovici, M.
    Bulocinic, S.
    Radu, P.
    Atsmon, J.
    Shmuely, E.
    Laba, O.
    Gadish, D.
    Brendel, E.
    Schwartz, B.
    ANNALS OF ONCOLOGY, 2004, 15 : 87 - 88
  • [36] PHASE-I STUDY OF PHOSPHONACETYL-L-ASPARTATE, 5-FLUOROURACIL, AND LEUCOVORIN IN PATIENTS WITH ADVANCED CANCER
    HAGEBOUTROS, A
    ROGATKO, A
    NEWMAN, EM
    MCALEER, C
    BRENNAN, J
    LACRETA, FP
    HUDES, GR
    OZOLS, RF
    ODWYER, PJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 35 (03) : 205 - 212
  • [37] A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors
    Ryan, DP
    Lynch, TJ
    Grossbard, ML
    Seiden, MV
    Fuchs, CS
    Grenon, N
    Baccala, P
    Berg, D
    Finkelstein, D
    Mayer, RJ
    Clark, JW
    CANCER, 2000, 88 (01) : 180 - 185
  • [38] An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
    Caponigro, F.
    Lacombe, D.
    Twelves, C.
    Bauer, J.
    Govaerts, A. -S.
    Marreaub, S.
    Milano, A.
    Anthoney, A.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 48 - 55
  • [39] A phase I/pharmacologic study of UCN-01 in combination with 5-fluorouracil in patients with advanced solid tumors.
    Shah, MA
    Kortmansky, J
    Kelsen, DP
    Hseuh, C
    Kaubisch, A
    Spriggs, D
    Gonen, M
    Tong, W
    Endres, S
    Schwartz, GK
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3710S - 3710S
  • [40] A Phase I study of hepatic arterial infusion of oxaliplatin in combination with systemic fluorouracil, leucovorin and bevacizumab in patients with advanced solid tumors metastatic to the liver
    Tsimberidou, Apostolia
    Hong, David
    Ng, Chaan
    Wheler, Jennifer
    Naing, Aung
    Bedikian, Agop
    Eng, Cathy
    Fortier, Adoneca
    Uehara, Cynthia
    Kurzrock, Razelle
    CANCER RESEARCH, 2009, 69
12345